GILUPI CellCollector
home CellCollector about gilupi news contact
german version
Management
Departments
Collaborations
Careers
Investors

Collaborations

GILUPI works closely with nationally and internationally recognized clinical and academic partners to meet the clinical and diagnostic requirements of our products.

Among others:


Cooperating partners

PD Dr. med. Frank König Aturoberlin.de
specialists for Urology and Andrology
Novelcheck Berlin
Lab for Cancer Diagnostics
Dr. Thomas Krahn,
Dr. Antje Stresemann

Bayer Pharma AG
Global Biomarker Research

 
Prof. Dr. med. Klaus Pantel University Medical Center Hamburg-Eppendorf
Department of Tumor Biology
 
1

Clinical partners

DE Leiden University Medical Center (LUMC) , Department of Clinical Oncology, project with European Uro- Oncology Group (EUOG)

Clinical study Prostate cancer
“An Exploratory Phase 2, open-label, single-arm, efficacy and imaging Study of Oral Enzalutamide (MDV3100) Androgen Receptor (AR)-Directed Therapy in Chemo-Naïve patients with Progressive Prostate Cancer who have failed Androgen Deprivation Therapy (CRPC patients)”
and
“An Exploratory Phase 2, open-label, single-arm, efficacy and imaging Study of Oral Enzalutamide (MDV3100) Androgen Receptor (AR)-Directed Therapy in Hormono-Naïve patients with Metastatic Prostate Cancer who have never before received Androgen Deprivation Therapy (Hormono-naïve patients)”

Prof. Dr. J. Burggraaf
Prof. Dr. S. Osanto

Interview with Prof. S. Osanta

DE SRH Wald-Klinikum Gera, Certified lung cancer center (DKG)

Case Series LUNG
Significance of in vivo isolation of circulating tumor cells (CTCs) for the treatment and follow-up care of non-small cell lung cancer (NSCLC)

PD Dr. med. habil. Thomas Lesser

D University Hospital Düsseldorf, Department of General-, Visceral- and Pediatric Surgery, Germany Case series COLON CANCER

“Isolation of circulating tumor cells from peripheral blood of patients with colorectal cancer by using a structured antibody-coated detector (FSMW)”

Prof. Dr. med. Nikolas H. Stoecklein
Prof. Dr. med. Wolfram T. Knoefel
D University Hospital Halle (Saale), Policlinic for Internal Medicine I, Department of Pneumology, Germany Case series LUNG CANCER

“Isolation of circulating tumor cells from peripheral blood of patients with lung cancer by using a structured antibody-coated detector (FSMW)”

Dr. med. B. Schmidt
Dr. rer nat. M. Fleischhacker
DE University Hospital Halle (Saale),

Germany Case series BREAST
Clinical Application of Detektor CANCER01 for the in vivo isolation of CTCs in mammacarcinoma patients and comparative characterization between CTCs and primary tumor tissue

Prof. Dr. med. Christoph Thomssen
Dr. rer. nat. Martina Vetter
Antonia Müller

D University Medical Center Ulm, Clinic for Internal Medicine II, Department of Pneumology, Germany Case series LUNG CANCER

“Isolation of circulating tumor cells from peripheral blood of patients with lung cancer by using a structured antibody-coated detector (FSMW)”

PD Dr. med. C. Schumann
DE University Hospital Halle (Saale), Clinic and Policlinic for Urology, Kidney Transplantation Center Germany

Clinical study PROSTATE - completed

ISRCTN10403616

“Isolation of circulating tumor cells from peripheral blood of patients with prostate cancer by using a structured antibody-coated nanodetector (FSMW)”

Prof. Dr. P. Fornara
A. Schumann
Dr. G. Theil

D University Hospital Greifswald, Clinic and Policlinic for Gynecology and Obstetrics Case series BREAST CANCER
Clinical validation of Detektor CANCER02 for the isolation and characterization of circulating tumor cells in breast cancer patients – Identification and comparison of detection rates under therapy

Prof. Dr. med. Marek Zygmunt
Henriette Wenig

University Hospital of South Manchester
North West Lung Centre

The University of Manchester, Cancer Research UK Manchester Institute
Clinical and Experimental Pharmacology Group

Case series LUNG CANCER
An investigation of a novel circulating tumour cell detection device in non-small cell lung cancer (NSCLC)

Dr Phil Crosbie
Mr Rajesh Shah
Prof Caroline Dive

IRCCS Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) S.r.l., Meldola, Italy Case series LUNG CANCER
EML4-ALK status investigation in Circulating Tumor Cells in NSCLC advanced in adenocarcinoma patients: preliminary investigation using an in vivo recovery procedure

Dr. Francesco Fabbri, Dr.ssa Martina Zoli, Dr.ssa Giulia Gallerani, Dr.ssa Maddalena Tumedei, Prof. Amadori, Dr. W. Zoli
DUniversity Complex Hospital from Santiago de Compostela (SERGAS), Liquid biopsy analysis Unit, Traslational Medical Oncology Group, Fundacion Ramon Dominguez, Health Research Institute of Santiago (IDIS) Case series HEAD & NECK CANCER
Circulating tumour cells assessed by GILUPI CellCollector® and CELLSEARCH® System in advanced Head and Neck cancer patients

Dr. Rafael López López,
Dr. Laura Muinelo Romay,
Dr. Santiago Aguín Losada
1

Funding programs

Funded by The Ministry for Economic Affairs and European Affairs of the Federal State of Brandenburg and the EU

Fiber Optical Cell Collector and Sensor for the diagnosis of cardiovascular disease (FOCCS)
University of Potsdam: Dr. Dörte Steinbrück
Fraunhofer IAP: Dr. André Gessner
1
Sponsored by BMBF (Federal Ministry of Education and Research)

Liquid biopsy: In vivo capturing and molecular characterization of circulating tumor cells as a novel tool for improving tertiary prevention in breast cancer

Prof. Evi Lianidou, University of Athens, Laboratory of Analytical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab
Prof. Klaus Pantel, University Medical Center Hamburg-Eppendorf, Department of Tumor Biology
Prof. Dimitrios Mavroudis, University Hospital of Heraklion, Medical Oncology Clinicc
Prof. Amanda Psyrri, Attikon Hospital Athens, Oncology Unit
1

Participation in EU- funded international collaboration within the Innovative Medicines Initiative (IMI) „CANCER-ID”

Mehr Informationen unter http://www.cancer-id.eu

1

Participation in EU- funded international collaboration within FP7 program “CanDo-the CANcerDevelopment mOnitor consortium”

For more information www.fp7cando.eu

1
Participation in EU-funded international collaboration within the framework of ERA-NET on Translational Cancer Research (TRANSCAN)

“CTC-SCAN: Circulating Tumour Cells as Biomarker for Minimal Residual Disease in Prostate Cancer”

DE Germany

University Medical Center Hamburg-Eppendorf Department of Tumor Biology
France

University Medical Centre of Montpellier Saint-Eloi Hospital Department IRB Laboratory of Detection Rare Circulating Human Cells
GR Greece

University of Athens Department of Chemistry, Laboratory of Analytical Chemistry Analysis of Cirulating Tumor Cells (ACTC) Lab
A Austria

Medical University of Graz, Institute of Cell Biology, Histology and Embryology Center of Molecular Medicine
Pl Poland

Department of Histology and Embryology Medizinische Universität Posen
1
Federal Ministry of Education and Research (BMBF) - leading-edge cluster competition m4 Network Personalized Medicine

Hsp70 testkit validation and identification of circulating tumor cells for monitoring the response to a combinated radiochemo-adoptive NK cell therapy of NSCLC patients


DE Germany Technische Universität München, Klinikum rechts der Isar, Clinic and Policlinic for Radiation Therapy,
Department Radiation Oncology
Prof. Dr. G. Multhoff
1

Networks
DE Germany     
Netzwerk Diagnostik Berlin-Brandenburg
mnettbb

 

1